종근당바이오
063160KOSPI의약품 제조업41.5 / 100
Reference Date: 2026-04-13
Company InformationBased on 2025 Annual Report
Business Overview
CKDBio is a fermentation and biotechnology specialist established in 2001, operating core businesses in API, probiotics, microbiome, and botulinum toxin. Leveraging over 50 years of technical expertise and adherence to global cGMP standards, the company supplies high-value products to over 40 countries. In the botulinum toxin sector, it has secured China NMPA Phase 3 clinical approval, actively expanding its global market presence.
Number of Employees
533people
Average Salary
69.0M KRW
Score Calculation Basis
Detailed Financial Score
In line with industry avg
Well below industry avg
Higher than industry avg (caution)
Avg ▲0.2% (2-year basis)
Avg ▲43.6% (2-year basis)
Avg ROE -4.4% (improving, 3yr)
Detailed News Sentiment
- Neutral다이나믹바이오 15주년…"올해 3상 자료 제출 간소화 추진"
민관 협의체 '다이나믹바이오'가 출범 15주년을 맞아 임상시험 3상 자료 제출 간소화 등 인허가 절차 개선을 추진할 계획입니다.
- Neutral식약처, 민관협의체 다이나믹바이오 15주년 기념행사 개최
식품의약품안전처와 한국바이오의약품협회가 바이오의약품 민관 협의체 '다이나믹바이오' 15주년 기념행사를 개최했습니다.
- Neutral"바이오의약품 민관협의체 '다이나믹바이오' 출범 어느덧 15주년"
바이오의약품 산업 정책개발 및 제도개선 발굴을 위한 민관협의체 '다이나믹바이오'가 출범 15주년을 맞이했습니다.
Detailed Momentum
Near 52w low (7%, downtrend)
1m -2.82% (slight drop)
Volume decreasing
Detailed Disclosure
- Neutral정기주주총회결과2026-03-26
- Neutral사외이사의선임ㆍ해임또는중도퇴임에관한신고2026-03-26
- Neutral사업보고서 (2025.12)2026-03-18
- Neutral감사보고서제출2026-03-16
